By IDSE News Staff
The FDA approved artesunate for injection (Amivas) to treat severe malaria in adults and children. Treatment of severe malaria with IV artesunate should always be followed by a complete treatment course of an appropriate oral antimalarial regimen.
Before this approval, IV artesunate was only available to patients through the FDA’s Expanded Access program, which allowed the CDC to provide IV artesunate to U.S. patients with severe malaria and to patients with uncomplicated